Immunitybio Stock Performance

Immunitybio Relative Risk vs. Return Landscape

If you had invested $ 236.00 in Immunitybio on December 12, 2025 and sold it today you would have earned a total of $ 546.00 from holding Immunitybio or generated 231.36% return on investment over 90 days. Immunitybio is currently generating a 2.4593% daily expected return and carries 10.4663% risk (volatility on return distribution) over a 90-day horizon. In different words, 93% of stocks are less volatile than Immunitybio, and 51% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.This market-relative note looks at return potential and the amount of risk required to get it. It keeps the emphasis on benchmark context, not just standalone performance. Given the investment horizon of 90 days Immunitybio is expected to generate 13.53 times more return on investment than the market. However, the company is 13.53 times more volatile than its market benchmark. It trades about 0.23 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.04 per unit of risk.

Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Immunitybio has a beta of 0.22. This usually indicates as returns on the market go up, Immunitybio's average returns are expected to increase less than the benchmark. However, during a bear market, the loss from holding Immunitybio is expected to be smaller as well. In addition to that, Immunitybio has an alpha of 2.3966, implying that it can generate a 2.3966 percent excess return over Dow Jones Industrial after adjusting for the inherent market risk (beta).

Predictive Modules for Immunitybio

When forecasting Immunitybio, investors benefit from applying a variety of techniques rather than relying on a single method. The stock market is inherently unpredictable, but systematic comparison of different model outputs helps investors develop a more balanced perspective and prepare for alternative scenarios.

Hype Prediction Low Estimated High 0.50 10.02 20.46 Details

Intrinsic Valuation Low Real High 0.48 9.50 19.94 Details

Naive Forecast Low Next High 0.13 6.65 17.09 Details

5 Analysts Consensus Low Target High 13.88 15.25 16.93 Details

The most actionable insights from Immunitybio analysis often emerge from peer comparison rather than standalone review. Immunitybio's metrics gain meaning when benchmarked against the best and worst performers in its sector.

Primary Risk Indicators

Dramatic market swings over the past two decades have made risk management essential for stock investors. Immunitybio has been affected by sudden drops and strong recoveries alike. A hedging approach that tracks Immunitybio's volatility and fundamental risk indicators can help investors in Immunitybio limit the impact of adverse moves.

Immunitybio Alerts and Suggestions

For Immunitybio investors, automated alerts provide a systematic way to monitor the stock for actionable developments. Immunitybio notifications highlight changes in key indicators that could influence investment decisions.

Immunitybio Price Density Drivers

Immunitybio Fundamentals Growth